Synthesis and characterization of novel 5-allyl-6-{(benzo[d]thiazol-2-yl)methyl}-2-(alkylsulfanyl)oxopyrimidine derivatives
- Authors: Khalifa N.M.1,2, Al-Omar M.A.1, Amr A.E.1,3
-
Affiliations:
- Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy
- Department of Therapeutical Chemistry, Pharmaceutical and Drug Industries Division
- Applied Organic Chemistry Department
- Issue: Vol 86, No 12 (2016)
- Pages: 2752-2758
- Section: Article
- URL: https://journals.rcsi.science/1070-3632/article/view/216881
- DOI: https://doi.org/10.1134/S1070363216120367
- ID: 216881
Cite item
Abstract
A series of novel S-DABO analogues bearing thiazolo[3,2-a]pyrimidine and pyrimido[2,1-b][1,3]thiazine has been developed starting from 5-allyl-6-{(benzo[d]thiazol-2-yl)methyl}-2,3-dihydro-2-thioxopyrimidin-4(1H)-one. Selective S-alkylation was achieved to give the title compounds which were cyclized and oxidized to the corresponding sulfones.
About the authors
N. M. Khalifa
Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy; Department of Therapeutical Chemistry, Pharmaceutical and Drug Industries Division
Author for correspondence.
Email: nagykhalifa@hotmail.com
Saudi Arabia, Riyadh, 11451; Dokki, Cairo, 12622
M. A. Al-Omar
Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy
Email: nagykhalifa@hotmail.com
Saudi Arabia, Riyadh, 11451
A. E. Amr
Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy; Applied Organic Chemistry Department
Email: nagykhalifa@hotmail.com
Saudi Arabia, Riyadh, 11451; Dokki, Cairo, 12622